1,2-Dichloroethane → N-(5-furan-2-yl-isoxazol-3-yl)-3-pyridin-2-yl-acrylamide

HRID 606282Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 606282
[N:1]1[CH:6]=[CH:5][CH:4]=[CH:3][C:2]=1[CH:7]=[CH:8][C:9]([OH:11])=O.[O:12]1[CH:16]=[CH:15][CH:14]=[C:13]1[C:17]1[O:21][N:20]=[C:19]([NH2:22])[CH:18]=1.C1C=CC2N(O)N=NC=2C=1.C(Cl)CCl>CN(C=O)C>[O:12]1[CH:16]=[CH:15][CH:14]=[C:13]1[C:17]1[O:21][N:20]=[C:19]([NH:22][C:9](=[O:11])[CH:8]=[CH:7][C:2]2[CH:3]=[CH:4][CH:5]=[CH:6][N:1]=2)[CH:18]=1

Komponenten

6

Edukt 4

HCID 111,2-DichloroethaneHCID 757711-HydroxybenzotriazoleHCID 2478243-(2-Pyridyl)acrylic acidHCID 132302595-(Furan-2-yl)isoxazol-3-amine

Produkt 1

HCID 67047568N-(5-furan-2-yl-isoxazol-3-yl)-3-pyridin-2-yl-acrylamideAusbeute 36 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6228DimethylformamideLösungsmittel

Versuchsvorschrift

To a solution of 6 mg of 3-pyridin-2-yl-acrylic acid and 6 mg of 5-furan-2-yl-isoxazol-3-ylamine in DMF were added 8 mg of HOBt, 9 mg of EDC and 0.014 mL of TEA. The reaction solution was stirred for 18 hrs at room temperature, followed by concentration under reduced pressure. The concentrate was purified by preparative HPLC to provide 4 mg of N-(5-furan-2-yl-isoxazol-3-yl)-3-pyridin-2-yl-acrylamide. (Yield: 36%).

Aufarbeitung

  1. concentrationfollowed by concentration under reduced pressure
  2. customThe concentrate was purified by preparative HPLC

Quellen und Nachweise

ORD-Eintrag
ord-b668bced9f59491b94c4f4a2666273b0
Quelldatensatz
uspto-grants-2011_03
Patentnummer
US07915297B2

Notizen zur Reaktion

Wird geladen…